Understanding inherited neurological disorders
Official title: Clinical and Molecular Manifestations of Inherited Neurological Disorders
Run by National Institutes of Health Clinical Center (CC) · NCT00004568 · Data updated 2026-11-12
This study is trying to learn more about inherited neurological disorders by looking at the medical history and genetics of people who have or might have these conditions.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 2 Years to 120 Years |
| Sex | All |
| Enrollment | 3500 (estimated) |
| Sponsor | National Institutes of Health Clinical Center (CC) NIH |
| Locations | 2 sites (Bethesda, Maryland and 1 other locations) |
| Status | Recruiting |
| Started | February 18, 2000 |
| Registry record updated | October 27, 2026 |
| Trial ID | NCT00004568 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals of all ages with known or suspected inherited neurological disorders, as well as their unaffected relatives.
✕Probably not a fit
Patients with non-genetic neurological conditions or those without a family history of inherited neurological disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore the natural history and genetic factors of inherited neurological disorders, including various types of muscular and motor neuron diseases. Participants, both diagnosed and undiagnosed, will undergo comprehensive medical evaluations, including family history assessments and genetic testing. The study seeks to create a resource for future research and improve understanding of these rare conditions. By gathering detailed clinical data and biological samples, the research will contribute to the identification of causative mutations and potential new genes associated with these disorders.
Why it matters
Potential benefit: If successful, this study could enhance the understanding and diagnosis of inherited neurological disorders, leading to better management and treatment options for patients.
How similar studies have gone: Other studies focusing on the genetic basis of neurological disorders have shown promise, indicating that this approach could yield valuable insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
* Participants include those with inherited neurological conditions based on the training and research needs of the Neurogenetics Branch program. There is no logical limit; however, the total number of participants that can be enrolled in the protocol will be restricted. No more than 3,500 participants with either diagnosed or undiagnosed neurological conditions and their unaffected relatives will be enrolled in this evaluation and diagnostic protocol. INCLUSION CRITERIA: Participants will be eligible if they: * Have either a known or suspected, inherited neurological disease, OR are an unaffected relative (first-, second-, third, or higher degree relative) of a participant with a genetic neurological disease. * Have the ability to understand and sign an informed consent or have a parent/legal guardian to do so if they are minor children or a legal guardian to provide consent for adults without consent capacity. * Aged 2 years and above. EXCLUSION CRITERIA: Participants will not be eligible if they: -Have a systemic disease that compromises the ability to provide adequate neurologic examination or diagnosis. An example of this would be a contagious disease that would compromise our ability to do an adequate neurological exam.
Where it's running
-
National Institutes of Health Clinical Center
Bethesda, Maryland, United States Recruiting -
University of Mali
Bamako, Mali Completed
Study contacts
- Principal investigator: A. Reghan Foley, M.D. — National Institute of Neurological Disorders and Stroke (NINDS)
- Study coordinator: Whitney M Spencer
- Email: whitney.spencer@nih.gov
- Phone: (301) 402-6668
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Registering medical data and care outcomes for ALS, SMA, and other motor disorders
This registry slowly collects routine-care information from adults with ALS, SMA, or other motor disorders to see how they’re treated and how care affects outcomes.
-
VM100: a nutritional supplement to see if it improves quality of life for boys with Duchenne
This Phase 2 study tests VM100, a nutritional drink, in boys aged 8 and up with Duchenne muscular dystrophy to see if it can improve quality of life and reduce fatigue.
-
AOC 1044 in Duchenne Muscular Dystrophy with Exon 44 Skipping
This study tests whether intravenous AOC 1044 helps boys with Duchenne muscular dystrophy caused by mutations amenable to exon 44 skipping.
-
Amino acids plus diet and exercise for people with FSHD
This trial will test whether taking essential amino acid supplements together with a structured diet and exercise program helps adults with FSHD build muscle, reduce fat, and improve physical performance compared with placebo and matched healthy adults.
-
How physical functioning relates to quality of life for people with ALS at TidalHealth
This study will see if physical functioning scores relate to quality of life for adults with ALS who receive care at TidalHealth Peninsula Regional.
-
Portable markerless video system to measure walking in adults with neuromuscular conditions or healthy volunteers.
This project will test a portable video device that measures walking patterns to see if it can track gait changes in adults with neuromuscular diseases and in healthy volunteers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.